U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.4727T>C (p.Met1576Thr) AND not specified

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jun 19, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000181531.17

Allele description [Variation Report for NM_000138.5(FBN1):c.4727T>C (p.Met1576Thr)]

NM_000138.5(FBN1):c.4727T>C (p.Met1576Thr)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.4727T>C (p.Met1576Thr)
Other names:
p.M1576T:ATG>ACG
HGVS:
  • NC_000015.10:g.48467958A>G
  • NG_008805.2:g.182831T>C
  • NM_000138.5:c.4727T>CMANE SELECT
  • NP_000129.3:p.Met1576Thr
  • NP_000129.3:p.Met1576Thr
  • LRG_778t1:c.4727T>C
  • LRG_778:g.182831T>C
  • LRG_778p1:p.Met1576Thr
  • NC_000015.9:g.48760155A>G
  • NM_000138.4:c.4727T>C
Protein change:
M1576T
Links:
dbSNP: rs776625874
NCBI 1000 Genomes Browser:
rs776625874
Molecular consequence:
  • NM_000138.5:c.4727T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000539146Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Feb 3, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000695549Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Jun 19, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome.

Rommel K, Karck M, Haverich A, von Kodolitsch Y, Rybczynski M, Müller G, Singh KK, Schmidtke J, Arslan-Kirchner M.

Hum Mutat. 2005 Dec;26(6):529-39.

PubMed [citation]
PMID:
16220557
See all PubMed Citations (9)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000539146.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This variant is present in HGMD in 2 papers, associated with Marfan syndrome. It is present in one individual with isolated dilation of the ascending aorta and one with Marfan syndrome. It is classified in ClinVar with 2 stars as VUS by GeneDx and Invitae. The variant has a Max MAF in ExAC of 0.015% (10 alleles) and in gnomAD of 0.02% (31 alleles). Max prevalence of Marfan is 1/3000. This AA is not conserved and Zebra Finch has a Thr at this position.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000695549.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: FBN1 c.4727T>C (p.Met1576Thr) results in a non-conservative amino acid change located in the TB domain (IPR017878) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 252050 control chromosomes, predominantly at a frequency of 0.00024 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 2-fold the estimated maximal expected allele frequency for a pathogenic variant in FBN1 causing Aortopathy phenotype (0.00011), suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.4727T>C has been reported in the literature in at least one individual with an unknown bicuspid aortic valve phenotype (e.g. Gillis_2017). The variant has also been reported in the literature in individuals with Adolescent Idiopathic Scoliosis and suspected Marfan Syndrome (e.g. Rommel_2005, Rybczynski_2008, Sheikhzadeh_2012, Buchan_2014, Madar_2019, Damrauer_2019). Several of the individuals described in these reports underwent clinical genetics evaluations and had a normal range of Ghent systemic features (4 to 5 points, e.g. Buchan_2014, Madar_2019) or were reported without cardiac involvement (e.g. Damrauer_2019). The patients described by Buchan et al. were reported to have normal echocardiograms and ophthalmological evaluations, and no family history of aortic aneurysm or scoliosis, therefore suggesting possible lack of co-segregation with disease. These reports do not provide unequivocal conclusions about association of the variant with Aortopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 24833718, 31211626, 28659821, 26333736, 31163209, 16220557, 19012347, 21883168). Eight ClinVar submitters (evaluation after 2014) have cited the variant; seven submitters classified the variant as uncertain significance, and one submitter classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as VUS-possibly benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 13, 2025